Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Intervalo de año de publicación
1.
Medwave ; 14(1)ene.-feb. 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-716753

RESUMEN

La región vulvovaginal es una zona muy compleja por todos los elementos que la conforma y puede ser origen de un gran número de tumores benignos y en menor frecuencia de tumores malignos. En las últimas décadas, los tumores vulvovaginales han tenido un avance significativo en cuanto a su diagnóstico y tratamiento, dado por las aportaciones de la biología celular y molecular. El presente artículo pretende ser una referencia práctica para el diagnóstico clínico e histopatológico de estos tumores benignos así como en el tratamiento ambulatorio de algunos de ellos y su vigilancia.


The vulvovaginal region is a very complex area because of its anatomy and the fact that it can be source of a large number of benign tumors and less frequent malignant tumors. In recent decades, there have been significant gains in the diagnosis and treatment of vulvovaginal tumors, thanks to the contributions of cellular and molecular biology. The purpose of this review article is to serve as a practical reference for clinical and pathological diagnosis as well as in the outpatient treatment and monitoring of these benign tumors.


Asunto(s)
Femenino , Neoplasias Fibroepiteliales/cirugía , Neoplasias Fibroepiteliales/diagnóstico , Neoplasias de la Vulva/cirugía , Neoplasias de la Vulva/diagnóstico , Diagnóstico Diferencial , Neoplasias Fibroepiteliales/patología , Neoplasias de la Vulva/patología , Pólipos/cirugía , Pólipos/diagnóstico
2.
Ginecol Obstet Mex ; 72: 385-93, 2004 Aug.
Artículo en Español | MEDLINE | ID: mdl-15526554

RESUMEN

BACKGROUND: Preterm labor continues to be the first cause (after congenital malformations) of morbidity and mortality during the perinatal period. One of the markers showing the highest sensitivity to predict preterm labor seems to be fetal fibronectin (fFN) determined in the cervicovaginal secretion. OBJECTIVES: To identify patients at risk of preterm labor based on the presence of fFN in cervicovaginal secretions and to analyze the cost-benefit of medical attention and hospital stay depending on the fFN results. MATERIAL AND METHODS: Four hundred and sixty two patients were admitted in a 6 month period to the Maternal-Fetal Medicine Department. All of them had symptoms of preterm labor. Their gestational ages were between 24 and 34 weeks, the fFN analyses were taken from cervical vaginal secretion. One hundred and fifty eight were fFN positive and 304 were negative. Patients with positive fFN were hospitalized and received specific treatment for preterm labor. The patients with negative fFN were sent home with no medical treatment. In order to calculate the economic impact of the hospital's medical attention we considered the total cost in pesos which included patient's hospital care when admitted with preterm labor symptoms, hospital stay, and neonatal attention. The total costs were compared and analyzed in the two groups. RESULTS: The average cost generated for fFN positive and negative patients was 23,059 and 7,859 pesos, respectively. Approximately 15,200 pesos were saved per patient in this group. Multiplying this amount among patients with negative fFN (n=304), we would have saved 4,620,000 pesos in a 6 month period. Our established medical management did not affect negatively maternal-fetal well being. For statistical purposes of variables the Mann Whitney U, chi square and McNemar's tests were calculated. CONCLUSION: By determining fFN for the diagnosis of preterm labor, we obtained savings of 4,620,000 pesos in a 6 month period avoiding unnecessary treatments and hospital stay in patients with negative fFN. Determination of fFN in cervical vaginal secretion in patients with symptoms of preterm labor showed to have high sensitivity and specificity in predicting preterm labor between 24-34 weeks of gestation, permitting a more rational use of medical management and resources and avoiding unnecessary treatments. The treatment instituted on the basis of an opportune diagnosis in patients with positive fFN showed to prolong weeks of gestation. Although a persistence of morbidity and mortality of prematurity has been reported, these have diminished in comparison with studies previously done in the institution.


Asunto(s)
Fibronectinas/análisis , Glicoproteínas/análisis , Trabajo de Parto Prematuro/economía , Líquidos Corporales/química , Cuello del Útero , Análisis Costo-Beneficio , Femenino , Humanos , Embarazo , Estudios Prospectivos , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...